DE3471934D1 - 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives, their preparation and use as medicaments - Google Patents

7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives, their preparation and use as medicaments

Info

Publication number
DE3471934D1
DE3471934D1 DE8484401391T DE3471934T DE3471934D1 DE 3471934 D1 DE3471934 D1 DE 3471934D1 DE 8484401391 T DE8484401391 T DE 8484401391T DE 3471934 T DE3471934 T DE 3471934T DE 3471934 D1 DE3471934 D1 DE 3471934D1
Authority
DE
Germany
Prior art keywords
dihydro
ethyl
carboxylic acid
pyrrol
oxoquinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484401391T
Other languages
English (en)
Inventor
Soler Jose Esteve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATORIOS DEL DR. ESTEVE S.A., BARCELONA, ES
Original Assignee
Provesan SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8311250A external-priority patent/FR2548664B1/fr
Application filed by Provesan SA filed Critical Provesan SA
Application granted granted Critical
Publication of DE3471934D1 publication Critical patent/DE3471934D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE8484401391T 1983-07-06 1984-06-29 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives, their preparation and use as medicaments Expired DE3471934D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8311250A FR2548664B1 (fr) 1983-07-06 1983-07-06 Derives 7-(pyrrol-l-yl) des acides l-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxyliques et l-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitues, leur preparation et leur application en tant que medicaments
FR8402145A FR2559484B2 (fr) 1983-07-06 1984-02-13 Nouveau derive 7-(pyrrol-1-yl) de l'acide 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridin)-3-carboxylique, sa preparation et son application en tant que medicament

Publications (1)

Publication Number Publication Date
DE3471934D1 true DE3471934D1 (en) 1988-07-14

Family

ID=26223521

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484401391T Expired DE3471934D1 (en) 1983-07-06 1984-06-29 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives, their preparation and use as medicaments

Country Status (21)

Country Link
US (1) US4552882A (de)
EP (1) EP0134165B1 (de)
KR (1) KR880002355B1 (de)
AT (1) ATE34982T1 (de)
AU (1) AU564326B2 (de)
BR (1) BR8403342A (de)
CA (1) CA1256876A (de)
CS (1) CS244139B2 (de)
DD (1) DD223150A5 (de)
DE (1) DE3471934D1 (de)
DK (1) DK163126C (de)
ES (1) ES8503335A1 (de)
FR (1) FR2559484B2 (de)
GR (1) GR81646B (de)
HK (1) HK10491A (de)
HU (1) HU189916B (de)
MX (1) MX156436A (de)
NO (1) NO163329C (de)
PL (1) PL143730B1 (de)
PT (1) PT78854B (de)
YU (1) YU43577B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2574404B1 (fr) * 1984-12-12 1987-04-24 Provesan Sa Derives 1-substitues de l'acide 6-fluoro-7-(pyrrol-1-yl)-1,4-dihydro-4-oxoquinoleine-3-carboxylique, leur preparation et leur application en tant que medicaments
DE3519286A1 (de) * 1985-05-30 1986-12-04 Bayer Ag, 5090 Leverkusen 7-azolyl-1-cyclopropyl-1,4-dihydro-4-oxo-3- chinolincarbonsaeuren und -1,8-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4692454A (en) * 1986-02-03 1987-09-08 Warner-Lambert Company Opthalmic use of quinolone antibiotics
DE3615767A1 (de) * 1986-05-10 1987-11-12 Bayer Ag Verfahren zur herstellung von 4-hydroxy-chinolin-3-carbonsaeuren
FR2607504B1 (fr) * 1986-12-02 1989-01-27 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
ES2051225B1 (es) * 1992-07-23 1994-12-16 Esteve Quimica Sa Procedimiento de preparacion del acido 1-etil-6-fluoro-7-(pirrol-1-il) -1,4-dihidro-4-oxo-3-quinoleincarboxilico.
EP2147679B1 (de) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Zusammensetzungen für den Blut-Hirn-Schrankentransport
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN104803975A (zh) * 2015-04-24 2015-07-29 河南大学 一种氨甲基三唑取代的二氟喹诺酮羧酸类衍生物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1006521A (en) * 1972-12-18 1977-03-08 Minoru Sugita Piperazine derivatives and process for preparing them
JPS5233694A (en) * 1975-09-09 1977-03-14 Dai Ichi Seiyaku Co Ltd Process for preparation of 6_nitro-1,8-naphthyridine derivatives
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
JPS5649382A (en) * 1979-09-28 1981-05-02 Dainippon Pharmaceut Co Ltd 6-fluoro-7-cyclic amino-1,8-naphthylidine derivative and its salt

Also Published As

Publication number Publication date
BR8403342A (pt) 1985-06-18
YU119084A (en) 1986-12-31
NO163329C (no) 1990-05-09
YU43577B (en) 1989-08-31
ES533749A0 (es) 1985-03-01
NO842717L (no) 1985-01-07
DK163126B (da) 1992-01-20
HUT34482A (en) 1985-03-28
PT78854B (fr) 1986-10-23
CS528584A2 (en) 1985-08-31
FR2559484B2 (fr) 1986-09-26
GR81646B (de) 1984-12-11
DD223150A5 (de) 1985-06-05
FR2559484A2 (fr) 1985-08-16
AU2942584A (en) 1985-01-10
PL248545A1 (en) 1985-07-16
PL143730B1 (en) 1988-03-31
US4552882A (en) 1985-11-12
HU189916B (en) 1986-08-28
DK163126C (da) 1992-06-15
ATE34982T1 (de) 1988-06-15
KR850001198A (ko) 1985-03-16
EP0134165B1 (de) 1988-06-08
NO163329B (no) 1990-01-29
DK331384A (da) 1985-01-07
EP0134165A3 (en) 1985-10-09
AU564326B2 (en) 1987-08-06
EP0134165A2 (de) 1985-03-13
KR880002355B1 (ko) 1988-10-29
MX156436A (es) 1988-08-22
ES8503335A1 (es) 1985-03-01
DK331384D0 (da) 1984-07-05
HK10491A (en) 1991-02-13
CA1256876A (en) 1989-07-04
PT78854A (fr) 1984-08-01
CS244139B2 (en) 1986-07-17

Similar Documents

Publication Publication Date Title
DE3471934D1 (en) 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives, their preparation and use as medicaments
EP0163599A3 (en) Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents
AU589427B2 (en) Pyridonecarboxylic acid derivatives and process for their preparation
EP0422485A3 (en) Quinolone carboxylic acid derivatives, process for their preparation and their use
ZA94841B (en) Novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid
ES8802148A1 (es) Procedimiento para preparar derivados de acido quinoloncarboxilico
NZ229861A (en) 2,5,6-trisubstituted pyridine-3-carboxylic acids and acid derivatives
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
DE3464603D1 (en) 2-anilino-1,6-dihydro-6-oxo-5-pyrimidinecarboxylic acid derivatives, processes for the preparation thereof, and antiallergic agent containing the same
ES2004255A6 (es) Procedimiento de preparar compuestos del tipo de las piracinas y analogos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LABORATORIOS DEL DR. ESTEVE S.A., BARCELONA, ES

8328 Change in the person/name/address of the agent

Free format text: GRUENECKER, A., DIPL.-ING. KINKELDEY, H., DIPL.-ING. DR.-ING. STOCKMAIR, W., DIPL.-ING. DR.-ING. AE.E. CAL TECH SCHUMANN, K., DIPL.-PHYS. DR.RER.NAT. JAKOB, P., DIPL.-ING. BEZOLD, G., DIPL.-CHEM. DR.RER.NAT. MEISTER, W., DIPL.-ING. HILGERS, H., DIPL.-ING. MEYER-PLATH, H., DIPL.-ING. DR.-ING. EHNOLD, A., DIPL.-ING. SCHUSTER, T., DIPL.-PHYS. GOLDBACH, K., DIPL.-ING.DR.-ING. AUFENANGER, M., DIPL.-ING. KLITZSCH, G., DIPL.-ING. VOGELSANG-WENKE, H., DIPL.-CHEM. DIPL.-BIOL.UNIV. DR.RER.NAT., PAT.-ANWAE

8339 Ceased/non-payment of the annual fee